Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 08:21:20 UTC |
---|
Update Date | 2021-09-26 23:02:53 UTC |
---|
HMDB ID | HMDB0251077 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate |
---|
Description | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate belongs to the class of organic compounds known as leucine and derivatives. Leucine and derivatives are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Based on a literature review very few articles have been published on Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate. This compound has been identified in human blood as reported by (PMID: 31557052 ). Ethyl (2s,3s)-3-[[(2s)-1-[[(2s)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CCOC(=O)C1OC1C(=O)NC(CC(C)C)C(=O)NC(CO)CC#C InChI=1S/C17H26N2O6/c1-5-7-11(9-20)18-15(21)12(8-10(3)4)19-16(22)13-14(25-13)17(23)24-6-2/h1,10-14,20H,6-9H2,2-4H3,(H,18,21)(H,19,22) |
---|
Synonyms | Value | Source |
---|
Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylic acid | Generator |
|
---|
Chemical Formula | C17H26N2O6 |
---|
Average Molecular Weight | 354.403 |
---|
Monoisotopic Molecular Weight | 354.179086565 |
---|
IUPAC Name | ethyl 3-({1-[(1-hydroxypent-4-yn-2-yl)carbamoyl]-3-methylbutyl}carbamoyl)oxirane-2-carboxylate |
---|
Traditional Name | ethyl 3-({1-[(1-hydroxypent-4-yn-2-yl)carbamoyl]-3-methylbutyl}carbamoyl)oxirane-2-carboxylate |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCOC(=O)C1OC1C(=O)NC(CC(C)C)C(=O)NC(CO)CC#C |
---|
InChI Identifier | InChI=1S/C17H26N2O6/c1-5-7-11(9-20)18-15(21)12(8-10(3)4)19-16(22)13-14(25-13)17(23)24-6-2/h1,10-14,20H,6-9H2,2-4H3,(H,18,21)(H,19,22) |
---|
InChI Key | ZPCQZAJQTXDACB-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as leucine and derivatives. Leucine and derivatives are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Leucine and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Leucine or derivatives
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid amide
- Fatty acyl
- Oxirane carboxylic acid or derivatives
- Oxirane carboxylic acid
- N-acyl-amine
- Fatty amide
- Secondary carboxylic acid amide
- Carboxylic acid ester
- Carboxamide group
- Acetylide
- Oxacycle
- Organoheterocyclic compound
- Monocarboxylic acid or derivatives
- Ether
- Oxirane
- Dialkyl ether
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Primary alcohol
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Alcohol
- Aliphatic heteromonocyclic compound
|
---|
Molecular Framework | Aliphatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 185.611 | 30932474 | DeepCCS | [M-H]- | 183.253 | 30932474 | DeepCCS | [M-2H]- | 216.233 | 30932474 | DeepCCS | [M+Na]+ | 191.704 | 30932474 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,2TMS,isomer #1 | C#CCC(CO[Si](C)(C)C)N(C(=O)C(CC(C)C)NC(=O)C1OC1C(=O)OCC)[Si](C)(C)C | 2470.4 | Semi standard non polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,2TMS,isomer #1 | C#CCC(CO[Si](C)(C)C)N(C(=O)C(CC(C)C)NC(=O)C1OC1C(=O)OCC)[Si](C)(C)C | 2486.7 | Standard non polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,2TMS,isomer #1 | C#CCC(CO[Si](C)(C)C)N(C(=O)C(CC(C)C)NC(=O)C1OC1C(=O)OCC)[Si](C)(C)C | 3378.9 | Standard polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,2TMS,isomer #2 | C#CCC(CO[Si](C)(C)C)NC(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)OCC)[Si](C)(C)C | 2455.9 | Semi standard non polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,2TMS,isomer #2 | C#CCC(CO[Si](C)(C)C)NC(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)OCC)[Si](C)(C)C | 2483.6 | Standard non polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,2TMS,isomer #2 | C#CCC(CO[Si](C)(C)C)NC(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)OCC)[Si](C)(C)C | 3337.0 | Standard polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,2TMS,isomer #3 | C#CCC(CO)N(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)OCC)[Si](C)(C)C)[Si](C)(C)C | 2420.1 | Semi standard non polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,2TMS,isomer #3 | C#CCC(CO)N(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)OCC)[Si](C)(C)C)[Si](C)(C)C | 2473.3 | Standard non polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,2TMS,isomer #3 | C#CCC(CO)N(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)OCC)[Si](C)(C)C)[Si](C)(C)C | 3405.0 | Standard polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,3TMS,isomer #1 | C#CCC(CO[Si](C)(C)C)N(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)OCC)[Si](C)(C)C)[Si](C)(C)C | 2485.4 | Semi standard non polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,3TMS,isomer #1 | C#CCC(CO[Si](C)(C)C)N(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)OCC)[Si](C)(C)C)[Si](C)(C)C | 2564.2 | Standard non polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,3TMS,isomer #1 | C#CCC(CO[Si](C)(C)C)N(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)OCC)[Si](C)(C)C)[Si](C)(C)C | 3050.6 | Standard polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,2TBDMS,isomer #1 | C#CCC(CO[Si](C)(C)C(C)(C)C)N(C(=O)C(CC(C)C)NC(=O)C1OC1C(=O)OCC)[Si](C)(C)C(C)(C)C | 2969.1 | Semi standard non polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,2TBDMS,isomer #1 | C#CCC(CO[Si](C)(C)C(C)(C)C)N(C(=O)C(CC(C)C)NC(=O)C1OC1C(=O)OCC)[Si](C)(C)C(C)(C)C | 2823.1 | Standard non polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,2TBDMS,isomer #1 | C#CCC(CO[Si](C)(C)C(C)(C)C)N(C(=O)C(CC(C)C)NC(=O)C1OC1C(=O)OCC)[Si](C)(C)C(C)(C)C | 3462.4 | Standard polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,2TBDMS,isomer #2 | C#CCC(CO[Si](C)(C)C(C)(C)C)NC(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)OCC)[Si](C)(C)C(C)(C)C | 2935.4 | Semi standard non polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,2TBDMS,isomer #2 | C#CCC(CO[Si](C)(C)C(C)(C)C)NC(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)OCC)[Si](C)(C)C(C)(C)C | 2835.0 | Standard non polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,2TBDMS,isomer #2 | C#CCC(CO[Si](C)(C)C(C)(C)C)NC(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)OCC)[Si](C)(C)C(C)(C)C | 3432.5 | Standard polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,2TBDMS,isomer #3 | C#CCC(CO)N(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)OCC)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2925.4 | Semi standard non polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,2TBDMS,isomer #3 | C#CCC(CO)N(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)OCC)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2827.2 | Standard non polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,2TBDMS,isomer #3 | C#CCC(CO)N(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)OCC)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3477.3 | Standard polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,3TBDMS,isomer #1 | C#CCC(CO[Si](C)(C)C(C)(C)C)N(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)OCC)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3194.7 | Semi standard non polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,3TBDMS,isomer #1 | C#CCC(CO[Si](C)(C)C(C)(C)C)N(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)OCC)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3085.4 | Standard non polar | 33892256 | Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate,3TBDMS,isomer #1 | C#CCC(CO[Si](C)(C)C(C)(C)C)N(C(=O)C(CC(C)C)N(C(=O)C1OC1C(=O)OCC)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3261.2 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate GC-MS (Non-derivatized) - 70eV, Positive | splash10-0040-7492000000-c8c7a7905b2abaaee23d | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate 10V, Negative-QTOF | splash10-0udi-1039000000-36728d0b3934b0ab2b7c | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate 20V, Negative-QTOF | splash10-016u-7592000000-2e200a98e3820faf0546 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate 40V, Negative-QTOF | splash10-0udi-4910000000-a773479233c87846511a | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate 10V, Positive-QTOF | splash10-0a4i-0029000000-6dccaa332c388fca5cb0 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate 20V, Positive-QTOF | splash10-06sr-4933000000-c8781f6b0b583095ef2d | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate 40V, Positive-QTOF | splash10-0j4u-9500000000-00d70ebd63badc90b464 | 2021-10-12 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | Not Available |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 156963342 |
---|
PDB ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]
|
---|